The prices charged by drug manufacturers to wholesalers and distributors (commonly referred to as exmanufacturers prices) in the United States are 1.8 times higher than in other countries for the top drugs by total expenditures separately paid under Medicare Part B. U.S. prices were higher for most of the drugs included in the analysis, and U.S.
Medicare
Reports
Displaying 61 - 70 of 190. 10 per page. Page 7.
Advanced SearchEnvironmental Scan
Types and Costs of Services for Dual Beneficiaries by Medicare Advantage Health Plans: An Environmental Scan
The Centers for Medicare and Medicaid Services (CMS) uses the Star Rating program to measure the quality of Medicare Advantage (MA) plans, publicly report plan performance, and determine quality bonus payments and rebates for MA plans.
Addressing Social Determinants of Health Needs of Dually Enrolled Beneficiaries in Medicare Advantage Plans: Findings from Interviews and Case Studies
Medicare Advantage (MA) plans that serve relatively higher proportions of dually enrolled beneficiaries have lower ratings in the MA Star Rating program than plans that serve fewer dually enrolled beneficiaries. However, some MA plans that serve a high proportion of dually enrolled beneficiaries are high performers.
ASPE Data Point
Data Point: Savings Available Under Full Generic Substitution of Multiple Source Brand Drugs in Medicare Part D
ASPE analyzed Part D prescription drug event data from 2016 to estimate spending on brand drugs with generic therapeutic equivalents.
Aging, Reentry, and Health Coverage: Barriers to Medicare and Medicaid for Older Reentrants
Linkage to health coverage upon release from prison or jail is a critical aspect of the reentry process that may promote greater personal stability and productivity, as well as better care coordination in the community health care system and subsequent reductions in state expenditures.
Review of Assumptions and Methods of the Medicare Trustees' Financial Projections
The Technical Review Panel on the Medicare Trustees Report was established by the Department of Health and Human Services in 2016 to review the assumptions and methods underlying the Medicare Trust Funds (Hospital Insurance and Supplementary Medical Insurance) annual reports to Congress.
Support and Services at Home (SASH) Evaluation: Evaluation of the First Four Years
This evaluation report describes the implementation and impacts of a program intended to improve health status and slow the growth of health care expenditures among older adults living in affordable housing properties. The Support and Services at Home (SASH) program connects participants with community-based services and promotes coordination of health care.
Support and Services at Home (SASH) Evaluation: Highlights from the First Four Years Research Summary
This Research Summary describes the primary features of the SASH program and summarizes the main findings of the evaluation to date. [7 PDF pages]
Report, Report to Congress
Report to Congress: Social Risk Factors and Performance Under Medicare's Value-Based Purchasing Programs
This report, mandated by the Improving Medicare Post-Acute Care Transformation Act of 2014 or the IMPACT Act (P.L. 113-185), requires the Secretary, acting through the Assistant Secretary for Planning and Evaluation (ASPE), to conduct research on issues related to socioeconomic status (SES) in Medicare’s value-based payment programs.
ASPE Issue Brief
Advancing Integrated Care: Lessons from Minnesota
Jhamirah M. Howard and Jennifer Baron Office of the Assistant Secretary for Planning and Evaluation Printer Friendly Version in PDF Format (8 PDF pages)